تجاوز إلى المحتوى الرئيسي
drug protocol number
CRAD001LIC01
drug sponsor
Novartis
drug study
Everolimus
drug trial site
King Faisal Specialist Hospital and Research Center (Riyadh)
drug status
Ongoing
drug phase